Company Filing History:
Years Active: 2022-2024
Title: Stian Foss: Innovator in Antibody Engineering
Introduction
Stian Foss is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of antibody engineering, holding a total of 2 patents. His work focuses on developing innovative solutions for antibody-mediated therapies.
Latest Patents
Stian Foss's latest patents include groundbreaking inventions in the realm of antibodies. The first patent, titled "Antibody variants," relates to antibodies that bind to TNFα and exhibit modified FcRn-binding. These antibodies demonstrate good effector functions and pharmacokinetic properties. The second patent, "Engineered immunoglobulins with altered FcRn binding," involves compositions and methods for antibody-mediated therapy, specifically engineered immunoglobulins with altered half-life.
Career Highlights
Throughout his career, Stian Foss has worked with esteemed organizations such as Universitetet i Oslo and Tillotts Pharma AG. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Stian has collaborated with notable colleagues, including Jan Terje Andersen and Inger Sandlie. These partnerships have further enriched his work and fostered innovation in the field of antibody research.
Conclusion
Stian Foss is a distinguished inventor whose work in antibody engineering has the potential to impact therapeutic approaches significantly. His patents reflect a commitment to advancing medical science and improving patient outcomes.